Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

7.1%

6 terminated/withdrawn out of 85 trials

Success Rate

87.2%

+0.7% vs industry average

Late-Stage Pipeline

20%

17 trials in Phase 3/4

Results Transparency

2%

1 of 41 completed trials have results

Key Signals

11 recruiting1 with results

Enrollment Performance

Analytics

N/A
44(66.7%)
Phase 3
10(15.2%)
Phase 4
7(10.6%)
Phase 2
4(6.1%)
Phase 1
1(1.5%)
66Total
N/A(44)
Phase 3(10)
Phase 4(7)
Phase 2(4)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (85)

Showing 20 of 85 trials
NCT07396961Not Yet Recruiting

Consistency of ASIS Line vs. Tuffier's Line for Lumbar Level Identification

Role: lead

NCT07336329Not ApplicableRecruiting

Continuous Glucose Monitoring in Non-Insulin Treated Type 2 Diabetes: Continuous vs. Periodic Use

Role: lead

NCT04769362Phase 4Recruiting

Long-term Beta-blocker Therapy After Acute Myocardial Infarction

Role: collaborator

NCT07298850Not ApplicableActive Not Recruiting

A Study on the Effect of CGM Alone on Glycemic Metrics in Type 2 Diabetes Patients Not Using Insulin, Without Additional Interventions

Role: lead

NCT07256977Not ApplicableNot Yet Recruiting

Minimally Invasive Radical Hysterectomy Using Endoscopic Stapler in Stage IB2 or IIA1 Cervical Cancer

Role: collaborator

NCT06124833Recruiting

Omics-driven Research on the Gut-Oral Microbiome, Metabolome, Lifestyle, and Clinical Integration in Korean Inflammatory Bowel Disease

Role: collaborator

NCT04738786Not ApplicableTerminated

Clinical Study Evaluating the Proper Surgical Safety Margin for Early Stage Oral Tongue Cancers

Role: collaborator

NCT06773585Not Yet Recruiting

Investigations of Factors Associated With Treatment Response and Prognosis in Anxiety Disorders

Role: lead

NCT06929897Not ApplicableNot Yet Recruiting

PVI Alone vs PVI With Posterior Wall Isolation for Pulse-Field Ablation in Persistent AF

Role: collaborator

NCT05255588Completed

A Stool DNA-based SDC2 Methylation Test for the Early Detection of Colorectal Cancer

Role: collaborator

NCT06594055Not ApplicableCompleted

Periodic Use of Continuous Glucose Monitoring With Personalized Diet Interventions Using AI Camera Among Non-insulin Treated Type 2 Diabetes

Role: lead

NCT04696757Phase 2Completed

Non-OpeRative MANagement of Rectal Cancer Patients

Role: lead

NCT05640830Phase 1Recruiting

Trastuzumab, Bevacizumab with Paclitaxel for HER2-positive Gastric Cancer in a Second-line Therapy

Role: lead

NCT06618638Not ApplicableRecruiting

Shared Decision Making for Choosing Autosomal DOminant Polycystic Kidney Disease Treatment

Role: collaborator

NCT05538741Not ApplicableCompleted

Hypotension After Anesthetic Induction with Remimazolam in Elderly

Role: lead

NCT06542627Not ApplicableRecruiting

Continuous Glucose Monitoring for Glucose and Weight Management in Prediabetes and Non-severe Type 2 Diabetes: A Prospective Community-based (Workplace) Cohort Study

Role: lead

NCT06454149Recruiting

Cohort Study for Gastric MALT Lymphoma

Role: collaborator

NCT02715518Not ApplicableCompleted

FFR Versus Angiography-Guided Strategy for Management of AMI With Multivessel Disease

Role: collaborator

NCT05810532Not ApplicableCompleted

NPO Before Sedation

Role: lead

NCT01917552Phase 3Recruiting

Adjuvant Capecitabine Versus Observation Alone in Curatively Resected Stage IB Gastric Cancer((KCSG ST14-05): CATALYSIS

Role: collaborator